DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Wood L, Bukowski RM, Dreicer R, Elson P, Garcia JA, Gilligan T, Mekhail T, Rini BI.
Temsirolimus (TEM) in metastatic renal cell carcinoma (mRCC):
Safety and efficacy in patients (pts) previously treated with VEGF-targeted
therapy.
J Clin Oncol 2008; 26
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.